Senior Director, Commercial Planning & Performance

Apnimed is a rapidly growing pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea (OSA) could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime.

Our lead development program, AD109, targets the neurologic control of upper airway muscles to maintain an open airway during sleep.

Apnimed is committed to innovation, as well as state-of-the-art advancements in sleep medicine,…